title: [Treatment of late-staged pancreatic carcinoma with implantation of 125I seeds in combination with regional arterial infusion chemotherapy].
abstract: OBJECTIVE
  To evaluate the effect of combined use of implantation of (125)I seeds with regional arterial infusion chemotherapy on late-staged pancreatic carcinoma.
  
  
  METHODS
  During operation, (125)I seeds were implanted into tumor parenchyma or operative beds for 7 patients with pathological diagnosis of late-staged pancreatic carcinoma, then chemotherapy pump was implanted into common hepatic artery or celiac artery through left gastric artery or right epigastric artery. Gemcitabine (1000 mg/m(2)) plus fluorouracil (500 mg/m(2)) was used for postoperative adjuvant chemotherapy once a week for 7 consecutive weeks.
  
  
  RESULTS
  The mean number of implanted (125)I seeds was 42 and the mean dose was 29.4 mCi. The mean follow-up time was 245 days. Rate of pain relief was 100%, metastasis foci was reduced in 2 cases. CA-19-9 Antigen level decreased to normal in all patients. Pancreatic fistula occurred in one case and was cured with conservative therapy.
  
  
  CONCLUSIONS
  The combination therapy is effective for late-staged pancreatic carcinoma, it brings symptom relief and improvement in quality of life.
authors.affiliation: Department of Hepatobiliary and Pancreatic Surgery, No.6 People's Hospital Affiliated to Shanghai Jiaotong University, Shanghai 200233, China.
authors.forename: Kai-xing
authors.initials: KX
authors.lastname: Ai
authors.forename: Qi
authors.initials: Q
authors.lastname: Zheng
authors.forename: Yang
authors.initials: Y
authors.lastname: Xia
authors.forename: Xin-yu
authors.initials: XY
authors.lastname: Huang
authors.forename: Jian-hua
authors.initials: JH
authors.lastname: Zou
authors.forename: Jun
authors.initials: J
authors.lastname: Yan
authors.forename: Jiang-yong
authors.initials: JY
authors.lastname: Mao
mesh_terms: D000368:Aged; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D001918:Brachytherapy / Q000009:adverse effects / Q000379:methods*; D017024:Chemotherapy, Adjuvant; D003131:Combined Modality Therapy; D005260:Female; D005500:Follow-Up Studies; D006801:Humans; D007261:Infusions, Intra-Arterial; D007457:Iodine Radioisotopes / Q000627:therapeutic use*; D008297:Male; D008875:Middle Aged; D010190:Pancreatic Neoplasms / Q000628:therapy*; D012189:Retrospective Studies; D016019:Survival Analysis; D016896:Treatment Outcome
chemical_list: D007457:Iodine Radioisotopes